Exact Mass: 472.1854
Exact Mass Matches: 472.1854
Found 183 metabolites which its exact mass value is equals to given mass value 472.1854
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5-Formiminotetrahydrofolic acid
5-Formiminotetrahydrofolic acid is a substrate for Formimidoyltransferase-cyclodeaminase. [HMDB] 5-Formiminotetrahydrofolic acid is a substrate for Formimidoyltransferase-cyclodeaminase.
alpha-L-Rhamnopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->3)-L-fucose
alpha-L-Rhamnopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->3)-L-fucose is found in green vegetables. alpha-L-Rhamnopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->3)-L-fucose is isolated from the partial acid hydrolysate of mucilage from the edible water plant junsai (Brasenia schreberi). Isolated from the partial acid hydrolysate of mucilage from the edible water plant junsai (Brasenia schreberi). alpha-L-Rhamnopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->3)-L-fucose is found in green vegetables.
2R,3S,4S,5R,6S)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[4-hydroxy-3-(3-methylbut-2-enyl)phenoxy]oxane-3,4,5-triol
(1S,7S,8S,9S)-11-acetoxy-10-chloro-1-isovaleroxy-7-[(R)-3-methylvaleroxy]-valtrate chlorohydrin|chlorovaltrate N
2-ethylene-3,5,6-trimethyl-4-phenol-1-O-beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranoside
(E)-4-hydroxy-3-methoxyphenylpropene 4-O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranoside|trans-isoeugenyl beta-rutinoside
1-(4-beta-D-glucopyranosyloxybenzyl) 4-methyl (2R)-2-isobutylmalate
8E-decaene-4,6-diyn-1-O-beta-D-glucopyranosyl(1-2)-beta-D-glucopyranoside
alpha-L-rhamnopyranosyl-(1-3)-O-alpha-L-rhamnopyranosyl-(1-2)-D-glucopyranose
alpha-L-Rhap-(1-3)-alpha-D-Galp-(1-3)-2,5-anhydro-D-mannitol
Eugenol rutinoside
Eugenol rutinoside is a natural product found in Sapindus mukorossi and Lilium mackliniae with data available.
C22H32O11_beta-D-Glucopyranoside, 4-hydroxy-3-(3-methyl-2-buten-1-yl)phenyl 6-O-[(2R,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]
2R,3S,4S,5R,6S)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[4-hydroxy-3-(3-methylbut-2-enyl)phenoxy]oxane-3,4,5-triol_major
2R,3S,4S,5R,6S)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[4-hydroxy-3-(3-methylbut-2-enyl)phenoxy]oxane-3,4,5-triol_33.3\\%
Cys Phe Phe Gly
Cys Phe Gly Phe
Cys Gly Phe Phe
Asp His Thr Thr
Asp Asn Pro Gln
Asp Asn Gln Pro
Asp Pro Asn Gln
Asp Pro Gln Asn
Asp Gln Asn Pro
Asp Gln Pro Asn
Asp Thr His Thr
Asp Thr Thr His
Glu His Ser Thr
Glu His Thr Ser
Glu Asn Asn Pro
Glu Asn Pro Asn
Glu Pro Asn Asn
Glu Ser His Thr
Glu Ser Thr His
Glu Thr His Ser
Glu Thr Ser His
Phe Cys Phe Gly
Phe Cys Gly Phe
Phe Phe Cys Gly
Phe Phe Gly Cys
Phe Gly Cys Phe
Phe Gly Phe Cys
Gly Cys Phe Phe
Gly Phe Cys Phe
Gly Phe Phe Cys
His Asp Thr Thr
His Glu Ser Thr
His Glu Thr Ser
His Ser Glu Thr
His Ser Thr Glu
His Thr Asp Thr
His Thr Glu Ser
His Thr Ser Glu
His Thr Thr Asp
Asn Asp Pro Gln
Asn Asp Gln Pro
Asn Glu Asn Pro
Asn Glu Pro Asn
Asn Asn Glu Pro
Asn Asn Pro Glu
Asn Pro Asp Gln
Asn Pro Glu Asn
Asn Pro Asn Glu
Asn Pro Gln Asp
Asn Gln Asp Pro
Asn Gln Pro Asp
Pro Asp Asn Gln
Pro Asp Gln Asn
Pro Glu Asn Asn
Pro Asn Asp Gln
Pro Asn Glu Asn
Pro Asn Asn Glu
Pro Asn Gln Asp
Pro Gln Asp Asn
Pro Gln Asn Asp
Gln Asp Asn Pro
Gln Asp Pro Asn
Gln Asn Asp Pro
Gln Asn Pro Asp
Gln Pro Asp Asn
Gln Pro Asn Asp
Ser Glu His Thr
Ser Glu Thr His
Ser His Glu Thr
Ser His Thr Glu
Ser Thr Glu His
Ser Thr His Glu
Thr Asp His Thr
Thr Asp Thr His
Thr Glu His Ser
Thr Glu Ser His
Thr His Asp Thr
Thr His Glu Ser
Thr His Ser Glu
Thr His Thr Asp
Thr Ser Glu His
Thr Ser His Glu
Thr Thr Asp His
Thr Thr His Asp
alpha-L-Rhamnopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->3)-L-fucose
BIS(2,2,6,6-TETRAMETHYL-3,5-HEPTANEDIONATO)STRONTIUM HYDRATE [SR(TMHD)2]
Temanogrel hydrochloride
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
Methotrexate hydrate
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents
[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]methanone
Benzeneacetic acid, alpha,3,4-tris[(trimethylsilyl)oxy]-, trimethylsilyl ester
1-{(2S,5S)-4-Fluoro-5-[(trityloxy)methyl]tetrahydrofuran-2-YL}pyrimidine-2,4(1H,3H)-dione
4-[3,5-Dihydroxy-6-(hydroxymethyl)-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-6-methyloxane-2,3,5-triol
Cys-Phe-Phe-Gly
A tetrapeptide composed of L-cysteine, two L-phenylalanine units and glycine joined in sequence by peptide linkages.
alpha-D-abequopyranosyl-(1->3)-[alpha-D-galactopyranosyl-(1->2)]-alpha-D-mannopyranose
6-deoxy-alpha-L-mannopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->2)-alpha-D-galactopyranose
alpha-L-rhamnosyl-(1->2)-beta-D-galactosyl-(1->4)-beta-L-rhamnose
alpha-D-Talp-(1-2)-[alpha-D-Abe-(1-3)]-alpha-D-Manp
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
6-[({4,5-Dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)methyl]oxane-2,3,4,5-tetrol
5-Formimidoyltetrahydrofolic acid
The 5-formimidoyl derivative of tetrahydrofolic acid.